<DOC>
	<DOC>NCT00466791</DOC>
	<brief_summary>Evaluate the behavioral effects of MTS in children aged 6-12 with ADHD</brief_summary>
	<brief_title>Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD</brief_title>
	<detailed_description>Evaluate the behavioral effects measured by the SKAMP deportment scale of MTS compared to placebo in children aged 6-12 with ADHD</detailed_description>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Primary diagnosis ADHD Total score of greater than or equal to 26 on ADHDRSIV IQ of greater than or equal to 80 Blood pressure measurements within 95th percentile for age, gender, height at screening and baseline Current controlled (requiring a restricted medication) or uncontrolled, comorbid psychiatric diagnosis (except ODD) Known nonresponder to psychostimulant treatment BMI for age greater than 90th percentile History of seizures during last 2 years Conduct Disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>